Last 12 months
Inside the activity.
0 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 8 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2014 Filed Apr 3, 2014 20:33 UTC |
Joyner J. DavidEVP, Sales & Account Services
|
Tax withholdingCommon Stock | 9,203 | $74.29 | $683,690.87 |
DisclosureSEC source: 0001127602-14-014001 · form4.xml · nonDerivative · entry 1 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,399 F1 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| April 01, 2014 Filed Apr 3, 2014 20:31 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
GrantStock Option · Derivative | 54,550 | $74.29 Strike: $74.29 | $4,052,519.50 |
DisclosureSEC source: 0001127602-14-013997 · form4.xml · derivative · entry 3 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,550 Underlying: Common Stock · 54,550 shares Expires 2021-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2015. Read SEC document |
| April 01, 2014 Filed Apr 3, 2014 20:31 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
GrantCommon Stock (restricted) | 8,749 | $74.29 | $649,963.21 |
DisclosureSEC source: 0001127602-14-013997 · form4.xml · nonDerivative · entry 2 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,991 F2 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2017 and 50% on 4/1/2019. Read SEC document |
| April 01, 2014 Filed Apr 3, 2014 20:31 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
Tax withholdingCommon Stock | 7,166 | $74.29 | $532,362.14 |
DisclosureSEC source: 0001127602-14-013997 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,247.059 F1 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| April 01, 2014 Filed Apr 3, 2014 20:35 UTC |
Denton David MEVP, CFO
|
GrantStock Option · Derivative | 62,943 | $74.29 Strike: $74.29 | $4,676,035.47 |
DisclosureSEC source: 0001127602-14-014003 · form4.xml · derivative · entry 5 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,943 Underlying: Common Stock · 62,943 shares Expires 2021-04-01 F4 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2015. Read SEC document |
| April 01, 2014 Filed Apr 3, 2014 20:35 UTC |
Denton David MEVP, CFO
|
GrantCommon Stock (restricted) | 100,000 | $74.29 | $7,429,000.00 |
DisclosureSEC source: 0001127602-14-014003 · form4.xml · nonDerivative · entry 3 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,662 F3 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse on 4/1/2021. Read SEC document |
| April 01, 2014 Filed Apr 3, 2014 20:35 UTC |
Denton David MEVP, CFO
|
GrantCommon Stock (restricted) | 10,095 | $74.29 | $749,957.55 |
DisclosureSEC source: 0001127602-14-014003 · form4.xml · nonDerivative · entry 2 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,662 F2 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2017 and 50% on 4/1/2019. Read SEC document |
| April 01, 2014 Filed Apr 3, 2014 20:35 UTC |
Denton David MEVP, CFO
|
Tax withholdingCommon Stock | 6,857 | $74.29 | $509,406.53 |
DisclosureSEC source: 0001127602-14-014003 · form4.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,883.7692 F1 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| April 01, 2014 Filed Apr 3, 2014 20:41 UTC |
Boratto Eva CSVP, Cont & Chief Acct Officer
|
GrantStock Option · Derivative | 18,882 | $74.29 Strike: $74.29 | $1,402,743.78 |
DisclosureSEC source: 0001127602-14-014008 · form4.xml · derivative · entry 9 Boratto Eva C · CIK 0001580827 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,882 Underlying: Common Stock · 18,882 shares Expires 2021-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2015. Read SEC document |
| April 01, 2014 Filed Apr 3, 2014 20:41 UTC |
Boratto Eva CSVP, Cont & Chief Acct Officer
|
GrantCommon Stock (restricted) | 3,028 | $74.29 | $224,950.12 |
DisclosureSEC source: 0001127602-14-014008 · form4.xml · nonDerivative · entry 1 Boratto Eva C · CIK 0001580827 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,531 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2017 and 50% on 4/1/2019. Read SEC document |
| April 01, 2014 Filed Apr 3, 2014 20:38 UTC |
GOLD STEPHEN JSVP & CIO
|
GrantStock Option · Derivative | 33,569 | $74.29 Strike: $74.29 | $2,493,841.01 |
DisclosureSEC source: 0001127602-14-014005 · form4.xml · derivative · entry 5 GOLD STEPHEN J · CIK 0001252005 · SVP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,569 Underlying: Common Stock · 33,569 shares Expires 2021-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2015. Read SEC document |
| April 01, 2014 Filed Apr 3, 2014 20:38 UTC |
GOLD STEPHEN JSVP & CIO
|
GrantCommon Stock (restricted) | 20,191 | $74.29 | $1,499,989.39 |
DisclosureSEC source: 0001127602-14-014005 · form4.xml · nonDerivative · entry 2 GOLD STEPHEN J · CIK 0001252005 · SVP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,536 F2 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse on 4/1/2019. Read SEC document |
| April 01, 2014 Filed Apr 3, 2014 20:38 UTC |
GOLD STEPHEN JSVP & CIO
|
GrantCommon Stock (restricted) | 5,384 | $74.29 | $399,977.36 |
DisclosureSEC source: 0001127602-14-014005 · form4.xml · nonDerivative · entry 1 GOLD STEPHEN J · CIK 0001252005 · SVP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,345 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2017 and 50% on 4/1/2019. Read SEC document |
| April 01, 2014 Filed Apr 3, 2014 20:53 UTC |
Roberts Jonathan CEVP & President, Caremark
|
GrantStock Option · Derivative | 73,433 | $74.29 Strike: $74.29 | $5,455,337.57 |
DisclosureSEC source: 0001127602-14-014015 · form4.xml · derivative · entry 6 Roberts Jonathan C · CIK 0001410515 · EVP & President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,433 Underlying: Common Stock · 73,433 shares Expires 2021-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2015. Read SEC document |
| April 01, 2014 Filed Apr 3, 2014 20:53 UTC |
Roberts Jonathan CEVP & President, Caremark
|
GrantCommon Stock (restricted) | 11,778 | $74.29 | $874,987.62 |
DisclosureSEC source: 0001127602-14-014015 · form4.xml · nonDerivative · entry 2 Roberts Jonathan C · CIK 0001410515 · EVP & President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,443 F2 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2017 and 50% on 4/1/2019. Read SEC document |
| April 01, 2014 Filed Apr 3, 2014 20:53 UTC |
Roberts Jonathan CEVP & President, Caremark
|
Tax withholdingCommon Stock | 2,026 | $74.29 | $150,511.54 |
DisclosureSEC source: 0001127602-14-014015 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,523.9286 F1 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| April 01, 2014 Filed Apr 3, 2014 20:50 UTC |
MERLO LARRY JDirector · President and CEO
|
GrantStock Option · Derivative | 335,697 | $74.29 Strike: $74.29 | $24,938,930.13 |
DisclosureSEC source: 0001127602-14-014012 · form4.xml · derivative · entry 6 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 335,697 Underlying: Common Stock · 335,697 shares Expires 2021-04-01 F2 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2015. Read SEC document |
| April 01, 2014 Filed Apr 3, 2014 20:50 UTC |
MERLO LARRY JDirector · President and CEO
|
GrantCommon Stock (restricted) | 53,843 | $74.29 | $3,999,996.47 |
DisclosureSEC source: 0001127602-14-014012 · form4.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 263,284 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2017 and 50% on 4/1/2019. Read SEC document |
| April 01, 2014 Filed Apr 3, 2014 20:44 UTC |
Sussman AndrewSVP & President, MinuteClinic
|
GrantStock Option · Derivative | 29,373 | $74.29 Strike: $74.29 | $2,182,120.17 |
DisclosureSEC source: 0001127602-14-014010 · form4.xml · derivative · entry 8 Sussman Andrew · CIK 0001515706 · SVP & President, MinuteClinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,373 Underlying: Common Stock · 29,373 shares Expires 2021-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2015. Read SEC document |
| April 01, 2014 Filed Apr 3, 2014 20:44 UTC |
Sussman AndrewSVP & President, MinuteClinic
|
GrantCommon Stock (restricted) | 4,711 | $74.29 | $349,980.19 |
DisclosureSEC source: 0001127602-14-014010 · form4.xml · nonDerivative · entry 1 Sussman Andrew · CIK 0001515706 · SVP & President, MinuteClinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,306 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2017 and 50% on 4/1/2019. Read SEC document |
| April 01, 2014 Filed Apr 3, 2014 20:54 UTC |
Bisaccia LisaSVP, Chief HR Officer
|
GrantStock Option · Derivative | 33,569 | $74.29 Strike: $74.29 | $2,493,841.01 |
DisclosureSEC source: 0001127602-14-014016 · form4.xml · derivative · entry 5 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,569 Underlying: Common Stock · 33,569 shares Expires 2021-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2015. Read SEC document |
| April 01, 2014 Filed Apr 3, 2014 20:54 UTC |
Bisaccia LisaSVP, Chief HR Officer
|
GrantCommon Stock (restricted) | 5,384 | $74.29 | $399,977.36 |
DisclosureSEC source: 0001127602-14-014016 · form4.xml · nonDerivative · entry 2 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,076.0004 F2 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2017 and 50% on 4/1/2019. Read SEC document |
| April 01, 2014 Filed Apr 3, 2014 20:54 UTC |
Bisaccia LisaSVP, Chief HR Officer
|
Tax withholdingCommon Stock | 3,086 | $74.29 | $229,258.94 |
DisclosureSEC source: 0001127602-14-014016 · form4.xml · nonDerivative · entry 1 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,202 F1 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| March 31, 2014 Filed Mar 31, 2014 20:56 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
SaleCommon Stock | 3,456 | $75.00 | $259,200.00 |
DisclosureSEC source: 0001127602-14-012981 · form4.xml · nonDerivative · entry 2 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,468.059 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| March 28, 2014 Filed Mar 31, 2014 20:56 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
SaleCommon Stock | 15,411 | $74.18 | $1,143,187.98 |
DisclosureSEC source: 0001127602-14-012981 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,924.059 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| February 19, 2014 Filed Feb 20, 2014 21:53 UTC |
Boratto Eva CSVP, Cont & Chief Acct Officer
|
Tax withholdingCommon Stock | 460 | $70.10 | $32,246.00 |
DisclosureSEC source: 0001127602-14-007477 · form4.xml · nonDerivative · entry 3 Boratto Eva C · CIK 0001580827 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,736.9542 F3 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| February 18, 2014 Filed Feb 20, 2014 21:37 UTC |
Roberts Jonathan CEVP & President, Caremark
|
GrantStock Unit | 18,486 | $70.32 | $1,299,935.52 |
DisclosureSEC source: 0001127602-14-007450 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,194.6057 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan, the receipt of which the reporting person has elected to defer. Read SEC document |
| February 18, 2014 Filed Feb 20, 2014 21:41 UTC |
MERLO LARRY JDirector · President and CEO
|
GrantStock Unit | 63,993 | $70.32 | $4,499,987.76 |
DisclosureSEC source: 0001127602-14-007462 · form4.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 473,996.4655 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan, the receipt of which the reporting person has elected to defer. Read SEC document |
| February 18, 2014 Filed Feb 20, 2014 21:42 UTC |
Foulkes HelenaEVP, President-CVS/pharmacy
|
GrantStock Unit | 11,376 | $70.32 | $799,960.32 |
DisclosureSEC source: 0001127602-14-007468 · form4.xml · nonDerivative · entry 1 Foulkes Helena · CIK 0001429996 · EVP, President-CVS/pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,334.2574 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan, the receipt of which the reporting person has elected to defer. Read SEC document |
| February 18, 2014 Filed Feb 20, 2014 21:44 UTC |
Denton David MEVP, CFO
|
GrantCommon Stock | 21,331 | $70.32 | $1,499,995.92 |
DisclosureSEC source: 0001127602-14-007471 · form4.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,438.7692 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan. Read SEC document |
| February 18, 2014 Filed Feb 20, 2014 21:45 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
GrantCommon Stock | 16,353 | $70.32 | $1,149,942.96 |
DisclosureSEC source: 0001127602-14-007473 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,335.059 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan. Read SEC document |
| February 18, 2014 Filed Feb 20, 2014 21:50 UTC |
Bisaccia LisaSVP, Chief HR Officer
|
GrantCommon Stock | 11,376 | $70.32 | $799,960.32 |
DisclosureSEC source: 0001127602-14-007475 · form4.xml · nonDerivative · entry 1 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,852 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan. Read SEC document |
| February 18, 2014 Filed Feb 20, 2014 21:47 UTC |
Joyner J. DavidEVP, Sales & Account Services
|
GrantCommon Stock | 2,844 | $70.32 | $199,990.08 |
DisclosureSEC source: 0001127602-14-007474 · form4.xml · nonDerivative · entry 1 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,667 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan. Read SEC document |
| February 18, 2014 Filed Feb 20, 2014 21:51 UTC |
Sussman AndrewSVP & President, MinuteClinic
|
GrantCommon Stock | 2,844 | $70.32 | $199,990.08 |
DisclosureSEC source: 0001127602-14-007476 · form4.xml · nonDerivative · entry 1 Sussman Andrew · CIK 0001515706 · SVP & President, MinuteClinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,829.0681 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan. Read SEC document |
| February 18, 2014 Filed Feb 20, 2014 21:53 UTC |
Boratto Eva CSVP, Cont & Chief Acct Officer
|
GrantCommon Stock (restricted) | 3,075 | $70.32 | $216,234.00 |
DisclosureSEC source: 0001127602-14-007477 · form4.xml · nonDerivative · entry 2 Boratto Eva C · CIK 0001580827 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,503 F2 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing February 18, 2015. Read SEC document |
| February 18, 2014 Filed Feb 20, 2014 21:53 UTC |
Boratto Eva CSVP, Cont & Chief Acct Officer
|
GrantCommon Stock | 2,844 | $70.32 | $199,990.08 |
DisclosureSEC source: 0001127602-14-007477 · form4.xml · nonDerivative · entry 1 Boratto Eva C · CIK 0001580827 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,817.9542 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan. Read SEC document |
| February 15, 2014 Filed Feb 18, 2014 21:01 UTC |
Joyner J. DavidEVP, Sales & Account Services
|
Tax withholdingCommon Stock | 527 | $69.90 | $36,837.30 |
DisclosureSEC source: 0001127602-14-006767 · form4.xml · nonDerivative · entry 1 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,823 F1 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| February 15, 2014 Filed Feb 18, 2014 21:02 UTC |
Boratto Eva CSVP, Cont & Chief Acct Officer
|
Tax withholdingCommon Stock | 293 | $69.90 | $20,480.70 |
DisclosureSEC source: 0001127602-14-006769 · form4.xml · nonDerivative · entry 1 Boratto Eva C · CIK 0001580827 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,812.8102 F1 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| February 07, 2014 Filed Feb 10, 2014 21:44 UTC |
Joyner J. DavidEVP, Sales & Account Services
|
Tax withholdingCommon Stock | 402 | $66.44 | $26,708.88 |
DisclosureSEC source: 0001127602-14-005381 · form4.xml · nonDerivative · entry 1 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,094 F1 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| February 07, 2014 Filed Feb 10, 2014 21:47 UTC |
Boratto Eva CSVP, Cont & Chief Acct Officer
|
Tax withholdingCommon Stock | 267 | $66.44 | $17,739.48 |
DisclosureSEC source: 0001127602-14-005387 · form4.xml · nonDerivative · entry 1 Boratto Eva C · CIK 0001580827 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,204.8102 F1 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| January 03, 2014 Filed Jan 3, 2014 23:12 UTC |
Lofberg Per GHEVP and President, Caremark
|
Exercise / conversionStock Option · Derivative | 53,124 | $0.00 Strike: $32.98 | $0.00 |
DisclosureSEC source: 0001127602-14-001013 · form4.xml · derivative · entry 16 Lofberg Per GH · CIK 0001318289 · EVP and President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 53,124 shares Expires 2020-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Option became exercisable on 12/31/2012. Read SEC document |
| January 03, 2014 Filed Jan 3, 2014 23:12 UTC |
Lofberg Per GHEVP and President, Caremark
|
Exercise / conversionStock Option · Derivative | 101,992 | $0.00 Strike: $36.23 | $0.00 |
DisclosureSEC source: 0001127602-14-001013 · form4.xml · derivative · entry 15 Lofberg Per GH · CIK 0001318289 · EVP and President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 101,992 shares Expires 2017-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: The Option becomes exercisable in three equal installments on April 1, 2011, April 1, 2012 and April 1, 2013, provided, however, that if the reporting person remains employed through December 31, 2012, then the option shall become exercisable in full as of December 31, 2012, and shall remain exercisable for one year following the reporting person's last date of employment with the Company. Read SEC document |
| January 03, 2014 Filed Jan 3, 2014 23:12 UTC |
Lofberg Per GHEVP and President, Caremark
|
Exercise / conversionStock Option · Derivative | 234,066 | $0.00 Strike: $34.96 | $0.00 |
DisclosureSEC source: 0001127602-14-001013 · form4.xml · derivative · entry 14 Lofberg Per GH · CIK 0001318289 · EVP and President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 234,066 shares Expires 2018-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Option became exercisable on 12/31/2012. Read SEC document |
| January 03, 2014 Filed Jan 3, 2014 23:12 UTC |
Lofberg Per GHEVP and President, Caremark
|
SaleCommon Stock | 53,124 | $70.61 | $3,751,085.64 |
DisclosureSEC source: 0001127602-14-001013 · form4.xml · nonDerivative · entry 8 Lofberg Per GH · CIK 0001318289 · EVP and President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,400 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F5 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $70.43 and $70.75 per share. Read SEC document |
| January 03, 2014 Filed Jan 3, 2014 23:12 UTC |
Lofberg Per GHEVP and President, Caremark
|
Exercise / conversionCommon Stock | 53,124 | $32.98 | $1,752,029.52 |
DisclosureSEC source: 0001127602-14-001013 · form4.xml · nonDerivative · entry 7 Lofberg Per GH · CIK 0001318289 · EVP and President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,524 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2014 Filed Jan 3, 2014 23:12 UTC |
Lofberg Per GHEVP and President, Caremark
|
SaleCommon Stock | 101,992 | $70.47 | $7,187,376.24 |
DisclosureSEC source: 0001127602-14-001013 · form4.xml · nonDerivative · entry 6 Lofberg Per GH · CIK 0001318289 · EVP and President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,400 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F4 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $70.26 and $70.71 per share. Read SEC document |
| January 03, 2014 Filed Jan 3, 2014 23:12 UTC |
Lofberg Per GHEVP and President, Caremark
|
Exercise / conversionCommon Stock | 101,992 | $36.23 | $3,695,170.16 |
DisclosureSEC source: 0001127602-14-001013 · form4.xml · nonDerivative · entry 5 Lofberg Per GH · CIK 0001318289 · EVP and President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,392 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2014 Filed Jan 3, 2014 23:12 UTC |
Lofberg Per GHEVP and President, Caremark
|
SaleCommon Stock | 234,066 | $70.47 | $16,494,631.02 |
DisclosureSEC source: 0001127602-14-001013 · form4.xml · nonDerivative · entry 4 Lofberg Per GH · CIK 0001318289 · EVP and President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,400 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F3 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $70.26 and $70.71 per share. Read SEC document |
| January 03, 2014 Filed Jan 3, 2014 23:12 UTC |
Lofberg Per GHEVP and President, Caremark
|
Exercise / conversionCommon Stock | 234,066 | $34.96 | $8,182,947.36 |
DisclosureSEC source: 0001127602-14-001013 · form4.xml · nonDerivative · entry 3 Lofberg Per GH · CIK 0001318289 · EVP and President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,466 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2014 Filed Jan 3, 2014 23:14 UTC |
Denton David MEVP, CFO
|
Exercise / conversionStock Option · Derivative | 14,113 | $0.00 Strike: $34.42 | $0.00 |
DisclosureSEC source: 0001127602-14-001016 · form4.xml · derivative · entry 6 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,113 shares Expires 2014-04-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/2/2008. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.